Wildlife Management and Rabies Epidemiology Notes

Wildlife Management

  • Lethal Approaches:

  • Proactive culling

  • Reactive culling

  • Selective culling


  • Non-lethal Approaches:

  • Surveillance

  • Spatial separation

  • Temporal separation

  • Veterinary medicines

  • Vaccines

Culling

  • General Use:

  • Commonly employed to control pest populations, also integral to disease management despite known limitations.

  • Types of Culling:

  • Proactive Culling:

    • Aims to reduce host/vector population before disease transmission; based on the assumption that transmission is density-dependent.

    • reduce density reduces size of problem

  • Reactive Culling:

    • Targets host/vector reduction post-disease transmission to mitigate further spread. Example: Management of foot-and-mouth disease via "cordon sanitaire."

    • Involves removing individuals from the population following an outbreak; focuses on controlling the immediate spread of the disease. This approach can help mitigate the risk of further infections, but it must be balanced with ethical considerations and the potential impact on the ecosystem. Proactive measures, such as vaccination programs and habitat management, are essential for long-term control of rabies in wildlife populations. Additionally, these proactive strategies can enhance population resilience and contribute to a healthier ecosystem, ultimately reducing the likelihood of future outbreaks.


  • Selective Culling:

    • Involves removing infected (potentially non-infectious) animals to minimize transmission, requiring strong surveillance and monitoring systems (e.g., managing bovine tuberculosis in cattle).


Rabies Overview

  • Modern Success Story:

  • Different dynamics in developed vs. developing nations; manageable due to the disease's characteristics but strategic efforts and luck have shaped outcomes.

  • Definition of Rabies:

  • Belongs to Order: Mononegavirales, Family: Rhabdoviridae, Genus: Lyssavirus (14 species).

  • A negative-sense RNA virus, with specific replication mechanisms hijacking host cellular machinery for transcription into mRNA.

  • Genome Structure:

  • 12 kilobases with 5 genes coding for viral proteins:

    • Nucleoprotein (N)

    • Phosphoprotein (P)

    • Matrix protein (M)

    • Glycoprotein (G)

    • Polymerase (L)

Rabies Virus Types

  • Commonly identified bat-related rabies viruses and characteristics of their primary hosts worldwide.

Primary Hosts of Rabies

  • Canine Rabies:

  • Primary host: dogs - canaine rabies ; Secondary (dead-end) hosts: humans cos dogs surrounded by dogs

  • Sylvatic Rabies:

  • Primary host: wildlife; includes livestock and humans as secondary hosts.

    Primary host: wild carnivores such as raccoons, foxes, and skunks; Secondary hosts: domestic animals and occasionally humans.

  • Bat Rabies: first developed rabies

  • Primary host: vampire bats feed on blood ; humans on feet and livestock are dead-end hosts.

Transmission and Symptoms

  • Transmission Cycle:

  • Generally occurs through bites of infected animals with varying incubation and infectious periods. need canine teeth to transmit.

  • Incubation Period:

    • Dogs: 2-16 weeks; Humans: 2-12 weeks.

      period varies cos of

    • Type of virus

      Severity of bite

      Amount of virus injected

      Immune status of host

      Proximity of the bite wound to the brain (children more likely to be bitten around the head)

  • Infectious Period:

    • Dogs: <5 days; Humans: Not applicable.

  • Symptoms: Two forms:

  • Encephalitic (“furious”) form: increased aggression.

    Other symptoms include:

    Hypersalivation

    Agitation

    Hallucinations / delerium

    Muscle weakness

    Coma

  • Paralytic (“dumb”) form: paralysis, reduced aggression.

Prognosis

  • Historically fatal with no survivors showing symptoms, rabies is now one of the most lethal diseases globally.

    death often from respiratory failure

  • 100% mortality rate

Treatment and Management

  • Vaccination Progress:

  • Historical development including Louis Pasteur's early vaccine and modern treatments focusing on education and pre/post-exposure prophylaxis.

  • Post-exposure Protocol:

  • Immediate rabies immunoglobulin and vaccination protocol tailored to exposure history.


    1.Immediate administration of rabies immunoglobulin

    2.Course of vaccinations

    If not previously vaccinated, receive five injections:

    Days 0, 3, 7, 14 and 30

    If previously vaccinated, receive two injections:

    Day 0 and Day 3-7

    Patient must make MULTIPLE trips; significant obstacle in countries with poor infrastructure

  • organ donation very rare


DEVELPMENT OF FIRST VACCINE

1879: accidentally develops a vaccine for chicken cholera

1880: starts to investigate rabies

1881: performs vaccine experiment against anthrax

1885: Successfully treats 9-year old Joseph Meister for rabies

Even though never used vaccine successfully before

Pasteur not a medical doctor, so not allowed to treat patients!

1886: presents paper on the successful treatment of over 350 patients with vaccine

All post-exposure

Patients start to arrive in Paris routinely for post-exposure treatment

MODERN DAY TREATMENT

Predominantly

Education

Major component

Pre-exposure prophylaxis (PrEP) (including vaccination of high-risk professions)

Post-exposure prophylaxis (PEP)

Major component

Challenges in Rabies Management

  • Reactive culling of dogs remains common, but proactive measures have gained focus, adverse social effects noted (e.g., increased aggression).

  • Social Dynamics in Dog Populations:

  • Maintaining social order post-culling is crucial to avoid increased aggression.

Epidemiological Insights

  • Reproductive Number (R0):

  • Threshold for disease stability in populations; values indicate necessity for reduction in transmission to manage outbreaks effectively.

  • Global Context:

  • A historical overview of rabies proliferation in various regions revealing consistent R0 values highlighting the challenges in control.

  • Vaccination Efforts:

  • Important vaccination coverage statistics showcasing disparities based on socio-economic factors and systemic support in various countries.

Conclusion

  • Future Directions:

  • WHO's objective for zero rabies deaths by 2030 highlights the urgent need for comprehensive control measures, particularly with canine rabies.